In last trading session, Eledon Pharmaceuticals Inc (NASDAQ:ELDN) saw 0.18 million shares changing hands with its beta currently measuring 0.72. Company’s recent per share price level of $4.26 trading at $0.01 or 0.24% at ring of the bell on the day assigns it a market valuation of $254.49M. That closing price of ELDN’s stock is at a discount of -30.05% from its 52-week high price of $5.54 and is indicating a premium of 73.94% from its 52-week low price of $1.11. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.27 million shares which gives us an average trading volume of 365.39K if we extend that period to 3-months.
For Eledon Pharmaceuticals Inc (ELDN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.34 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Eledon Pharmaceuticals Inc (NASDAQ:ELDN) trade information
Upright in the green during last session for gaining 0.24%, in the last five days ELDN remained trading in the green while hitting it’s week-highest on Wednesday, 11/27/24 when the stock touched $4.26 price level, adding 2.52% to its value on the day. Eledon Pharmaceuticals Inc’s shares saw a change of 136.67% in year-to-date performance and have moved 10.65% in past 5-day. Eledon Pharmaceuticals Inc (NASDAQ:ELDN) showed a performance of 18.66% in past 30-days. Number of shares sold short was 0.73 million shares which calculate 0.88 days to cover the short interests.
Eledon Pharmaceuticals Inc (ELDN) estimates and forecasts
Statistics highlight that Eledon Pharmaceuticals Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 65.12% of value to its shares in past 6 months, showing an annual growth rate of 61.59% while that of industry is 17.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 29.97% during past 5 years.
Eledon Pharmaceuticals Inc (NASDAQ:ELDN)’s Major holders
BVF INC/IL is the top institutional holder at ELDN for having 6.29 million shares of worth $16.61 million. And as of 2024-06-30, it was holding 20.985 of the company’s outstanding shares.
The second largest institutional holder is ARMISTICE CAPITAL, LLC, which was holding about 2.34 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.7894 of outstanding shares, having a total worth of $6.17 million.
